Oi Pharma Partners Ltd - Accounts to registrar (filleted) - small 23.2.5
Oi Pharma Partners Ltd - Accounts to registrar (filleted) - small 23.2.5
| Oi Pharma Partners Ltd |
| Financial Statements for the Year Ended 31 March 2024 |
| Oi Pharma Partners Ltd (Registered number: 07181658) |
| Contents of the Financial Statements |
| for the year ended 31 March 2024 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 3 |
| Oi Pharma Partners Ltd |
| Company Information |
| for the year ended 31 March 2024 |
| DIRECTOR: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| Chartered Certified Accountants |
| Red Sky House |
| Fairclough Hall, Halls Green |
| Weston |
| Hertfordshire |
| SG4 7DP |
| Oi Pharma Partners Ltd (Registered number: 07181658) |
| Balance Sheet |
| 31 March 2024 |
| 2024 | 2023 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| CURRENT ASSETS |
| Debtors | 5 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 6 |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CAPITAL AND RESERVES |
| Called up share capital |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| The director acknowledges her responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements were approved by the director and authorised for issue on |
| Oi Pharma Partners Ltd (Registered number: 07181658) |
| Notes to the Financial Statements |
| for the year ended 31 March 2024 |
| 1. | STATUTORY INFORMATION |
| Oi Pharma Partners Ltd is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Tangible fixed assets |
| Fixtures and fittings | - |
| Computer equipment | - |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | TANGIBLE FIXED ASSETS |
| Fixtures |
| and | Computer |
| fittings | equipment | Totals |
| £ | £ | £ |
| COST |
| At 1 April 2023 |
| Additions |
| Disposals | ( |
) | ( |
) |
| At 31 March 2024 |
| DEPRECIATION |
| At 1 April 2023 |
| Charge for year |
| Eliminated on disposal | ( |
) | ( |
) |
| At 31 March 2024 |
| NET BOOK VALUE |
| At 31 March 2024 |
| At 31 March 2023 |
| Oi Pharma Partners Ltd (Registered number: 07181658) |
| Notes to the Financial Statements - continued |
| for the year ended 31 March 2024 |
| 5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Prepayments |
| 6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2024 | 2023 |
| £ | £ |
| Trade creditors |
| Corporation tax |
| PAYE |
| VAT |
| Net wages | 1,557 | 2,315 |
| Directors' current accounts | 16,867 | 20,093 |
| Accrued expenses |